Ypsomed Holding AG buy melinda
Start price
05.07.17
/
50%
€176.65
Target price
27.12.17
€200.00
Performance (%)
-22.85%
End price
27.12.17
€136.28
Summary
This prediction ended on 27.12.17 with a price of €136.28. The price of Ypsomed Holding AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ypsomed Holding AG | - | - | - | - |
| iShares Core DAX® | -0.383% | 5.021% | 16.188% | 19.224% |
| iShares Nasdaq 100 | 1.248% | 4.007% | 36.579% | 57.508% |
| iShares Nikkei 225® | 0.525% | -0.109% | 12.378% | 9.329% |
| iShares S&P 500 | 0.640% | 3.649% | 28.752% | 47.932% |
Comments by melinda for this prediction
In the thread Ypsomed Holding AG diskutieren
Insulin-Pens hat
Der Bericht schließt mit Profilen der wichtigsten Akteure in der Insulin - Pens Markt wie Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. Die wichtigsten Marktteilnehmer werden auf verschiedenen Parametern wie Unternehmens - Übersicht, Perspektiven des Produkts und die neuesten Entwicklungen und Trends im Insulinpen Markt bewertet.
(Vom Mitglied beendet)
Stopped prediction by melinda for Ypsomed Holding AG
Ypsomed Holding AG
Start price
Target price
Perf. (%)
€176.65
05.07.17
05.07.17
€200.00
27.12.17
27.12.17
-22.85%
27.12.17
27.12.17
